Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis harrisbricken Views: 390

-

It’s been a while since we’ve discussed the status of hemp-derived cannabidiol (CBD) in the Golden State, and unfortunately, it may be a while before we have finality on its legal status. The bulk of the issues that the state faces today go back more than two years and amazingly, still have not been solved.

Problems began in July 2018, when the California Department of Public Health’s Food and Drug Branch (CDPH) published FAQ document that takes the position that CBD is unlawful in California (you can read my take on the FAQ here). Ever since the FAQ was published, there have been sporadic enforcement efforts across the state and a general stunting of a potentially massive market for CBD products. It did not have to be this way and efforts were undertaken to legislate away CDPH’s authority to effectively ban the industry.

In 2019, I must have written a dozen posts on the failed Assembly Bill 228, a law that would have regulated CBD in many consumer products in California. AB-228 made it almost to the finish line but, in the face of intense opposition, failed late in 2019.

In early 2020, Assembly Member Aguiar-Curry, the same Assembly Member who introduced AB-228, introduced AB-2827. As it was introduced, AB-2827 was a bare-bones bill that was likely intended to be substantially supplemented and eventually create a pathway for regulated CBD products. However, shortly after the bill was introduced, COVID-19 emerged and the bill has basically been sitting there unattended for months.

In May 2020, the Hemp Industry Daily reported that Aguiar-Curry would be reviving the bill in August 2020, prior to the close of 2020’s legislative session. It’s now August and while Aguiar-Curry has come out vocally in support of CBD legislation (see here, for example), the state has yet to move forward with actual legislation.

2020’s legislative session will not last much longer and if the legislature does not take the matter up in short order, it may be another six months until the state sees movement on CBD. To some extent, COVID-19 is to blame for the delays, but the state has had two years to address CBD and has not been able to yet. In fact, it seems as if California may even get lapped by the famously slow FDA at this point.

We here at the Canna Law Blog are hopeful that the state will change course and get things back on track for the many, many CBD businesses and entrepreneurs across the Golden State and beyond, that want to be compliant and offer quality CBD products. Until then, the industry’s stuck in CDPH’s unnecessary, self-created limbo. Stay tuned to the Canna Law Blog for more updates on California’s CBD industry.

Will California Ever “Legalize” CBD? on Harris Bricken.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.